Recon: US to build $300M Alzheimer’s database; BioNTech, DualityBio partner to develop ADC drugs in $1.5B deal
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy